Xontogeny
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio0 active
4Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
46Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
| Cerevel Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#108
Portfolio exits#49
Raises, 12 months#88
Co-investors#32
Co-investors
- Third Rock VenturesVenture capital3 shared
- Gurnet Point CapitalVenture capital2 shared
- Omega FundsVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- RA CapitalVenture capital2 shared
- Telegraph Hill PartnersVenture capital2 shared
- Valence Life SciencesVenture capital2 shared
- 5AM VenturesVenture capital1 shared
- AbbVieVenture capital1 shared
- Alexandria Venture InvestmentsVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.